Incidence and clinical outcome of abrupt vessel closure among patients receiving Abciximab during high-risk percutaneous coronary intervention: EPIC trial results

被引：0
|
作者：
Aguirre, FV [1 ]
Topol, EJ [1 ]
Leimberger, J [1 ]
Kleiman, N [1 ]
Lincoff, AM [1 ]
Donohue, TJ [1 ]
Califf, RM [1 ]
机构：
[1] ST LOUIS UNIV,CTR HLTH SCI,ST LOUIS,MO 63103
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1997年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8011 / 8011
页数：1
相关论文
共 50 条
  • [1] Abciximab effect on clinical and angiographic restenosis in high-risk patients with acute coronary syndrome undergoing percutaneous coronary intervention.: Results of the ISAR-REACT 2 trial
    Pache, Jurgen
    Mehilli, Julinda
    Kastrati, Adnan
    Bruskina, Olga
    Seyfarth, Melchior
    Dirschinger, Josef
    Schömig, Albert
    CIRCULATION, 2006, 114 (18) : 687 - 688
  • [2] Tirofiban, eptifibatide, and abciximab in minimizing myocardial damage during high-risk coronary intervention: Final results of the TEAM pilot trial
    Sharma, SK
    Kini, AS
    Perez, N
    Suleman, J
    Fisher, EA
    Marmur, JD
    Richard, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 73A - 73A
  • [3] Randomized comparison of tirofiban, eptifibatide, and abciximab in minimizing myocardial damage during high-risk percutaneous coronary intervention: TEAM pilot trial
    Sharma, SK
    Kini, A
    Perez, N
    Suleman, J
    Fisher, EA
    Marmur, JD
    Richard, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 642 - 642
  • [4] Clinical Predictors of Impella Dependence During High-Risk Percutaneous Coronary Intervention
    Sanborn, Luke
    Laifman, Eric
    Huang, Christie
    Tun, Han
    Matthews, Ray
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : S25 - S25
  • [5] Bivalirudin administration during percutaneous coronary intervention: Emphasis on high-risk patients
    Seybert, AL
    PHARMACOTHERAPY, 2002, 22 (06): : 112S - 118S
  • [6] Impact of hemodynamic support on outcome in patients undergoing high-risk percutaneous coronary intervention
    Shamekhi, J.
    Puetz, A.
    Zimmer, S.
    Tiyerili, V.
    Mellert, F.
    Welz, A.
    Fimmers, R.
    Grube, E.
    Nickenig, G.
    Werner, N.
    Sinning, J. M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1348 - 1348
  • [7] Impact of Hemodynamic Support on Outcome in Patients Undergoing High-Risk Percutaneous Coronary Intervention
    Shamekhi, Jasmin
    Puetz, Andrea
    Zimmer, Sebastian
    Tiyerili, Vedat
    Mellert, Fritz
    Welz, Armin
    Fimmers, Rolf
    Grube, Eberhard
    Nickenig, Georg
    Werner, Nikos
    Sinning, Jan-Malte
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (01): : 20 - 30
  • [8] Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention An Observational Registry Study
    Iversen, Allan Z.
    Galatius, Soeren
    Pedersen, Sune
    Madsen, Jan K.
    Jensen, Jan S.
    DRUGS & AGING, 2011, 28 (05) : 369 - 378
  • [9] Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study
    van Hout, BA
    Bowman, L
    Zelinger, DJ
    Simoons, ML
    EUROPEAN HEART JOURNAL, 1998, 19 : D59 - D66
  • [10] Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study
    van Hout, BA
    Bowman, L
    Zelinger, DJ
    Simoons, ML
    AMERICAN HEART JOURNAL, 1998, 135 (04) : S98 - S106
12345